{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:56:06Z","timestamp":1787003766467,"version":"build-2736575974"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"vor","delay-in-days":58,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Med"],"DOI":"10.1038\/s43856-026-01570-1","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T08:05:58Z","timestamp":1775549158000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cardiovascular risk assessment characterized by proteomics in cancer survivors"],"prefix":"10.1038","volume":"6","author":[{"given":"Peng","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fubin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kexin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangfang","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,7]]},"reference":[{"key":"1570_CR1","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","volume":"403","author":"GBD Diseases","year":"2024","unstructured":"Diseases, G. B. D. & Injuries, C. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet 403, 2133\u20132161 (2024).","journal-title":"Lancet"},{"key":"1570_CR2","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/S0140-6736(19)31674-5","volume":"394","author":"H Strongman","year":"2019","unstructured":"Strongman, H. et al. Medium and long-term risks of specific cardiovascular diseases in survivors of 20 adult cancers: a population-based cohort study using multiple linked UK electronic health records databases. Lancet 394, 1041\u20131054 (2019).","journal-title":"Lancet"},{"key":"1570_CR3","doi-asserted-by":"publisher","first-page":"3889","DOI":"10.1093\/eurheartj\/ehz766","volume":"40","author":"KM Sturgeon","year":"2019","unstructured":"Sturgeon, K. M. et al. A population-based study of cardiovascular disease mortality risk in US cancer patients. Eur. Heart J. 40, 3889\u20133897 (2019).","journal-title":"Eur. Heart J."},{"key":"1570_CR4","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1016\/j.jacc.2015.04.059","volume":"65","author":"A Barac","year":"2015","unstructured":"Barac, A. et al. Cardiovascular health of patients with cancer and cancer survivors: a roadmap to the next level. J. Am. Coll. Cardiol. 65, 2739\u20132746 (2015).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1570_CR5","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1002\/ejhf.1539","volume":"21","author":"RA de Boer","year":"2019","unstructured":"de Boer, R. A., Meijers, W. C., van der Meer, P. & van Veldhuisen, D. J. Cancer and heart disease: associations and relations. Eur. J. Heart Fail. 21, 1515\u20131525 (2019).","journal-title":"Eur. J. Heart Fail."},{"key":"1570_CR6","first-page":"309","volume":"66","author":"G Curigliano","year":"2016","unstructured":"Curigliano, G. et al. Cardiotoxicity of anticancer treatments: epidemiology, detection, and management. CA Cancer J. Clin. 66, 309\u2013325 (2016).","journal-title":"CA Cancer J. Clin."},{"key":"1570_CR7","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/s41569-024-01017-x","volume":"21","author":"NS Wilcox","year":"2024","unstructured":"Wilcox, N. S. et al. Cardiovascular disease and cancer: shared risk factors and mechanisms. Nat. Rev. Cardiol. 21, 617\u2013631 (2024).","journal-title":"Nat. Rev. Cardiol."},{"key":"1570_CR8","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","volume":"117","author":"RB D\u2019Agostino Sr.","year":"2008","unstructured":"D\u2019Agostino, R. B. Sr. et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 117, 743\u2013753 (2008).","journal-title":"Circulation"},{"key":"1570_CR9","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1093\/eurheartj\/ehab309","volume":"42","author":"SCORE2 Working Group and ESC Cardiovascular Risk Collaboration.","year":"2021","unstructured":"SCORE2 Working Group and ESC Cardiovascular Risk Collaboration. SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. Eur. Heart J. 42, 2439\u20132454 (2021).","journal-title":"Eur. Heart J."},{"key":"1570_CR10","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1093\/eurheartj\/ehab312","volume":"42","author":"SCORE2-OP Working Group and ESC Cardiovascular Risk Collaboration.","year":"2021","unstructured":"SCORE2-OP Working Group and ESC Cardiovascular Risk Collaboration. SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions. Eur. Heart J. 42, 2455\u20132467 (2021).","journal-title":"Eur. Heart J."},{"key":"1570_CR11","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.jaccao.2024.05.015","volume":"6","author":"C McCracken","year":"2024","unstructured":"McCracken, C. et al. Predictive performance of cardiovascular risk scores in cancer survivors from the UK Biobank. JACC CardioOncol. 6, 575\u2013588 (2024).","journal-title":"JACC CardioOncol."},{"key":"1570_CR12","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1001\/jama.2023.13258","volume":"330","author":"H Helgason","year":"2023","unstructured":"Helgason, H. et al. Evaluation of large-scale proteomics for prediction of cardiovascular events. JAMA 330, 725\u2013735 (2023).","journal-title":"JAMA"},{"key":"1570_CR13","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1093\/eurjpc\/zwae124","volume":"31","author":"P Royer","year":"2024","unstructured":"Royer, P. et al. Large-scale plasma proteomics in the UK Biobank modestly improves prediction of major cardiovascular events in a population without previous cardiovascular disease. Eur. J. Prev. Cardiol. 31, 1681\u20131689 (2024).","journal-title":"Eur. J. Prev. Cardiol."},{"key":"1570_CR14","doi-asserted-by":"publisher","unstructured":"Ho, J. E. et al. Protein biomarkers of cardiovascular disease and mortality in the community. J. Am. Heart Assoc. 7, https:\/\/doi.org\/10.1161\/JAHA.117.008108 (2018).","DOI":"10.1161\/JAHA.117.008108"},{"key":"1570_CR15","doi-asserted-by":"publisher","unstructured":"Ho, F. K. et al. A proteomics-based approach for prediction of different cardiovascular diseases and dementia. Circulation https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.124.070454 (2024).","DOI":"10.1161\/CIRCULATIONAHA.124.070454"},{"key":"1570_CR16","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41586-023-06592-6","volume":"622","author":"BB Sun","year":"2023","unstructured":"Sun, B. B. et al. Plasma proteomic associations with genetics and health in the UK Biobank. Nature 622, 329\u2013338 (2023).","journal-title":"Nature"},{"key":"1570_CR17","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1093\/bioinformatics\/17.6.520","volume":"17","author":"O Troyanskaya","year":"2001","unstructured":"Troyanskaya, O. et al. Missing value estimation methods for DNA microarrays. Bioinformatics 17, 520\u2013525 (2001).","journal-title":"Bioinformatics"},{"key":"1570_CR18","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1161\/01.cir.0000437741.48606.98","volume":"129","author":"DC Goff Jr","year":"2014","unstructured":"Goff, D. C. Jr et al. 2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. Circulation 129, S49\u2013S73 (2014).","journal-title":"Circulation"},{"key":"1570_CR19","doi-asserted-by":"publisher","unstructured":"Hippisley-Cox, J., Coupland, C. & Brindle, P. Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study. BMJ https:\/\/doi.org\/10.1136\/bmj.j2099 (2017).","DOI":"10.1136\/bmj.j2099"},{"key":"1570_CR20","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1001\/jama.2019.9879","volume":"322","author":"I Lourida","year":"2019","unstructured":"Lourida, I. et al. Association of lifestyle and genetic risk with incidence of dementia. JAMA 322, 430\u2013437 (2019).","journal-title":"JAMA"},{"key":"1570_CR21","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk, D. et al. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 51, D638\u2013D646 (2023).","journal-title":"Nucleic Acids Res."},{"key":"1570_CR22","doi-asserted-by":"crossref","unstructured":"DeLong, E. R., DeLong, D. M. & Clarke-Pearson, D. L. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 44, 837\u2013845 (1988).","DOI":"10.2307\/2531595"},{"key":"1570_CR23","doi-asserted-by":"publisher","first-page":"3125","DOI":"10.1016\/j.jtha.2024.07.019","volume":"22","author":"S Kraler","year":"2024","unstructured":"Kraler, S. et al. Biomarker-enhanced cardiovascular risk prediction in patients with cancer: a prospective cohort study. J. Thromb. Haemost. 22, 3125\u20133136 (2024).","journal-title":"J. Thromb. Haemost."},{"key":"1570_CR24","first-page":"791","volume":"2","author":"JA Alvarez-Cardona","year":"2020","unstructured":"Alvarez-Cardona, J. A. et al. Cardiac biomarkers during cancer therapy. Pract. Appl. Cardio-Oncol. JACC CardioOncol. 2, 791\u2013794 (2020).","journal-title":"Pract. Appl. Cardio-Oncol. JACC CardioOncol."},{"key":"1570_CR25","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.semcdb.2004.03.001","volume":"15","author":"E Ikonen","year":"2004","unstructured":"Ikonen, E. & Holtta-Vuori, M. Cellular pathology of Niemann-Pick type C disease. Semin. Cell Dev. Biol. 15, 445\u2013454 (2004).","journal-title":"Semin. Cell Dev. Biol."},{"key":"1570_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrrev.2019.108284","volume":"782","author":"Y Xu","year":"2019","unstructured":"Xu, Y., Zhang, Q., Tan, L., Xie, X. & Zhao, Y. The characteristics and biological significance of NPC2: mutation and disease. Mutat. Res. Rev. Mutat. Res. 782, 108284 (2019).","journal-title":"Mutat. Res. Rev. Mutat. Res."},{"key":"1570_CR27","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.cytogfr.2021.11.002","volume":"64","author":"JA Siddiqui","year":"2022","unstructured":"Siddiqui, J. A. et al. Pathophysiological role of growth differentiation factor 15 (GDF15) in obesity, cancer, and cachexia. Cytokine Growth Factor Rev. 64, 71\u201383 (2022).","journal-title":"Cytokine Growth Factor Rev."},{"key":"1570_CR28","doi-asserted-by":"publisher","unstructured":"Hou, C., Huo, J., Yan, S., Sun, F. & Yang, X. Identification of fibrosis-associated biomarkers in heart failure and human cancers. J. Transl. Med. 22, https:\/\/doi.org\/10.1186\/s12967-024-05759-7 (2024).","DOI":"10.1186\/s12967-024-05759-7"},{"key":"1570_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.112582","volume":"146","author":"QA Xiao","year":"2022","unstructured":"Xiao, Q. A., He, Q., Zeng, J. & Xia, X. GDF-15, a future therapeutic target of glucolipid metabolic disorders and cardiovascular disease. Biomed. Pharmacother. 146, 112582 (2022).","journal-title":"Biomed. Pharmacother."},{"key":"1570_CR30","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/j.cell.2019.07.033","volume":"178","author":"HH Luan","year":"2019","unstructured":"Luan, H. H. et al. GDF15 is an inflammation-induced central mediator of tissue tolerance. Cell 178, 1231\u20131244 (2019).","journal-title":"Cell"},{"key":"1570_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102322","volume":"52","author":"Y Wang","year":"2022","unstructured":"Wang, Y. et al. Overexpression of NAG-1\/GDF15 prevents hepatic steatosis through inhibiting oxidative stress-mediated dsDNA release and AIM2 inflammasome activation. Redox Biol. 52, 102322 (2022).","journal-title":"Redox Biol."},{"key":"1570_CR32","doi-asserted-by":"publisher","DOI":"10.1111\/apha.13377","volume":"228","author":"XF Pang","year":"2020","unstructured":"Pang, X. F., Lin, X., Du, J. J. & Zeng, D. Y. LTBP2 knockdown by siRNA reverses myocardial oxidative stress injury, fibrosis and remodelling during dilated cardiomyopathy. Acta Physiol. 228, e13377 (2020).","journal-title":"Acta Physiol."},{"key":"1570_CR33","doi-asserted-by":"publisher","unstructured":"Sideek, M. A. et al. A central bioactive region of LTBP-2 stimulates the expression of TGF-beta1 in fibroblasts via Akt and p38 signalling pathways. Int. J. Mol. Sci. 18, https:\/\/doi.org\/10.3390\/ijms18102114 (2017).","DOI":"10.3390\/ijms18102114"},{"key":"1570_CR34","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1373\/clinchem.2015.241232","volume":"61","author":"M Putt","year":"2015","unstructured":"Putt, M. et al. Longitudinal changes in multiple biomarkers are associated with cardiotoxicity in breast cancer patients treated with doxorubicin, taxanes, and trastuzumab. Clin. Chem. 61, 1164\u20131172 (2015).","journal-title":"Clin. Chem."},{"key":"1570_CR35","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1093\/jnci\/djaa096","volume":"113","author":"C Ramin","year":"2021","unstructured":"Ramin, C. et al. All-cause and cardiovascular disease mortality among breast cancer survivors in CLUE II, a long-standing community-based cohort. J. Natl. Cancer Inst. 113, 137\u2013145 (2021).","journal-title":"J. Natl. Cancer Inst."}],"container-title":["Communications Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01570-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01570-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01570-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T23:06:51Z","timestamp":1780528011000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01570-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,7]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1570"],"URL":"https:\/\/doi.org\/10.1038\/s43856-026-01570-1","relation":{},"ISSN":["2730-664X"],"issn-type":[{"value":"2730-664X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,7]]},"assertion":[{"value":"13 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"323"}}